Using data from its unique online research platform, 23andMe, a leading personal genetics company, has identified seven single-nucleotide polymorphisms (SNPs) significantly associated with breast size, including three SNPs also correlated with breast cancer in a genome-wide association study (GWAS) now published online in BMC Medical Genetics. These findings make the first concrete genetic link between breast size and breast cancer risks.
These findings were made analyzing data from 16,175 female 23andMe customers of European ancestry, comparing their answers to survey questions including bra cup size and bra band size to genetic data at millions of SNPs. The analysis controlled for age, genetic ancestry, breast surgeries, breast feeding status and pregnancy history.
"The 23andMe research platform is a robust source of new genetic discoveries and this study demonstrates that important scientific insights can come from the most unlikely places," stated 23andMe CEO and co-founder Anne Wojcicki. "Nearly 90 percent of our more than 150,000 customers participate in our online research allowing 23andMe to make discoveries faster and more cost effectively than traditional research models," added Wojcicki.
While some factors of breast morphology, such as density, are known to be directly implicated in breast cancer, the relationship between breast size and cancer is less clear. While breast size is heritable, this study is the first to identify genetic variants linked to differences in breast size.
"The findings in this study show that some of the same biological pathways underlie both normal breast growth and breast cancer," explained lead author Nicholas Eriksson, Ph.D. "Some studies have found that larger breast size as a young woman is associated with a slightly higher risk for breast cancer. The genetic factors we found support this concept that breast size and breast cancer are related."
The novel loci associated with breast size are rs7816345 near ZNF703, rs4849887 and rs17625845 flanking INHBB, rs12173570 near ESR1, rs7089814 in ZNF365, rs12371778 near PTHLH, and rs62314947 near AREG. Two of these SNPs are strongly correlated with SNPs associated with breast cancer (those near ESR1 and PTHLH), and a third (ZNF365) is near another breast cancer SNP. The other three loci (ZNF703, INHBB, and AREG) have strong links to estrogen regulation and breast development.
"These results provide insight into the genetic factors underlying normal breast development and show that some of these factors are shared with breast cancer," concluded Eriksson. "While these results do not directly support the known epidemiological relationships between breast size and cancer, this study contributes to a better understanding of the subtle interactions between breast morphology and breast cancer risk."
These breast size/breast cancer results continue to show the power of 23andMe's methodology in combining self-reported data on a broad range of phenotypes gathered via web-based questionnaires with genotypic data derived from self-collected saliva samples.
23andMe had previously published its first proof-of-concept results in the journal PLoS Genetics in June 2010, which reported novel associations for unusual traits such as asparagus anosmia and photic sneeze reflex and replicated associations for other common genetic traits, published the discovery of two novel genetic associations for Parkinson's disease in PLoS Genetics, and presented a major replication study of over 180 genetic associations in the journal PLoS ONE. In April of 2012, 23andMe published a study in the journal PLoS ONE which reported five novel significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. Most recently 23andMe published its finding of novel associations found for male pattern baldness, some of which are also linked to Parkinson's disease and prostate cancer, in PLoS Genetics.
23andMe customers see the results incorporated into the reports provided in their online accounts over time.
23andMe continues to be active in the investigation of breast cancer as it collaborates with Genentech in their InVite Study to understand how genes influence response to treatment for metastatic breast cancer. Anyone who has had metastatic breast cancer may be eligible to participate and can learn more at https://www.23andme.com/invite-study/ or by emailing email@example.com.About 23andMe
Media Contacts:Rubenstein Communications
Jane E. Rubinstein | EurekAlert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Health and Medicine
06.12.2016 | Life Sciences
05.12.2016 | Power and Electrical Engineering